Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for non-obstructive azoospermia
IRCT20140911019125N2Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Feb 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of PRGF-Endoret in male infertility and nonobstructive azoospermia (NOA), sponsored by Kerman University of Medical Sciences. Primary endpoints: Increase in sperm count in spermatogram, Improvement in spermatogenesis on biopsy and 1 more. Started Feb 2019; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
male infertilitynonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on IRCT20140911019125N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140911019125N2.